Interview from CEO Live at the 2018 Wall St Conference
with Mike Elliott of CEO Live and Dr. Stanley Hirsch Chairman of OWC Pharmaceutical Research Corp $OWCP
https://t.co/35DwfEgMmA
#MedicalMarijuana#MedicalCannabis
$OWCP News - OWC Pharmaceutical Research Corp. announces the successful completion of the first part of its Phase I, study (the “Psoriasis Study”) to determine the safety of topical ointment containing medical grade cannabis in healthy volunteers.
https://t.co/MVf0JZvb9r
$OWCP OWC Pharmaceutical Research Corp has completed the pre-clinical development of its next generation, orally-disintegrating tablet containing cannabis extract w/ specific amounts of cannabinoids tetrahydrocannabinol (“THC”) and cannabidol (“CBD”).
https://t.co/LcM6zhThm5
The future of Israel’s $1 billion-plus medical cannabis export industry has been tossed back to Prime Minister Benjamin Netanyahu for a decision after consideration by the parliamentary committee overseeing marijuana policy. https://t.co/d6X5YjA27D
Interview from CEO Live at the 2018 Wall St Conference
with Mike Elliott of CEO Live and
Dr. Stanley Hirsch Chairman of OWC Pharmaceutical Research Corp $OWCP
https://t.co/35DwfEgMmA
#MedicalMarijuana#MedicalCannabis
$OWCP NEWS
https://t.co/uecd44kCIs
OWCP has appointed Ms. Hannah Feuer to serve as a member
of the Board of Directors Audit Committee
OWCP was granted a PATENT in Australia, valid for a term of 8 years, should be
followed by additional patent grants in other jurisdictions @WSJ